128 matches for your search in the start-up spotlight
rss
Innovate Nordics targets Nordic growth companies aiming to establish a presence in the U.S. market
30-Apr-2025
Neogap Therapeutics, a Swedish biotechnology start-up developing personalised immunotherapy for cancer treatment, announced that it has been selected for the Innovate Nordics 2025 Acceleration Program, organised by the Swedish-American Chamber of Commerce in New York (SACCNY) in partnership with ...
Shorten research and development time for cancer drugs from 3 years to 12 months and significantly reduce development costs
24-Mar-2025
The German-Swiss biotechnology start-up BioCopy has secured new capital of 8 million euros. This sum is an important step for the company on its mission to produce more effective cancer drugs in the shortest possible time and at significantly lower costs. The company is supported by a group of ...
11-Mar-2025
Sun Pharmaceutical Industries Limited and Checkpoint Therapeutics, Inc. announced that they have entered into an agreement by which Sun Pharma will acquire Checkpoint, an immunotherapy and targeted oncology company. Checkpoint is a Nasdaq-listed commercial-stage company focused on developing ...
10-Mar-2025
Callio Therapeutics, a biotechnology company focused on realizing the promise of multi-payload antibody-drug conjugates (ADCs) to improve cancer therapy, today announced its launch with the closing of a $187.0 million Series A financing round. This financing was led by Frazier Life Sciences with ...
Tumour-on-chip model supports preclinical drug development on pancreatic cancer
10-Mar-2025
The biotech company Dynamic42, a specialist in organ-on-chip technology, has made a significant advance in pancreatic cancer drug research in collaboration with the research team of Prof. Dr. Nicole Teusch at the Institute of Pharmaceutical Biology and Biotechnology at Heinrich Heine University ...
03-Mar-2025
Improving treatment recommendations for colorectal cancer patients: This is the aim of a collaborative project between the University of Bonn, the company ESQlabs and the University Hospital Bonn (UKB), funded by the Federal Ministry of Education and Research. "ISPOT-K" combines organoids derived ...
Neogap Therapeutics' PIOR technology identifies targets for personalised liver cancer immunotherapies
17-Feb-2025
A new study published in the scientific journal Gut examines how immune system T cells respond to tumours in patients with advanced liver cancer (HCC). Using Neogap Therapeutics' PIOR® software platform, the researchers have identified tumour-specific mutations, which may contribute to the ...
Stem cell expert recently founded a spin-off to further explore the potential of IPTOs for drug testing
13-Feb-2025
Scientists from the German Cancer Research Center (DKFZ) and ShanghaiTech University have developed an innovative method for growing brain tumors of individual patients in the laboratory that mimic the original structure and the molecular property of the parental tumor as closely as possible. ...
Akribion is pioneering a unique, RNA-guided, nuclease-based technology for programmable cell depletion
06-Feb-2025
Akribion Therapeutics, the early-stage biotech developing a unique, RNA-guided, nuclease-based technology for programmable cell depletion, announces its exit from stealth and the completion of a Seed Financing round raising EUR 8 million to accelerate the development of novel therapeutics based ...
With nearly 1,500 entities, Europe hosts a larger number of cancer-related startups than the US
04-Feb-2025
Cancer remains a major health threat in Europe, which accounts for nearly 25% of global cases and over 20% of deaths, despite having less than 10% of the world's population[1]. Technological advancements are improving survival rates, with European healthcare systems showcasing excellence in ...
